Titre : Neurofibres

Neurofibres : Questions médicales fréquentes

Termes MeSH sélectionnés :

Language Development Disorders
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Neurofibres : Questions médicales les plus fréquentes", "headline": "Neurofibres : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Neurofibres : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-06", "dateModified": "2025-04-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Neurofibres" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Neurones", "url": "https://questionsmedicales.fr/mesh/D009474", "about": { "@type": "MedicalCondition", "name": "Neurones", "code": { "@type": "MedicalCode", "code": "D009474", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.671" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Neurofibres adrénergiques", "alternateName": "Adrenergic Fibers", "url": "https://questionsmedicales.fr/mesh/D000320", "about": { "@type": "MedicalCondition", "name": "Neurofibres adrénergiques", "code": { "@type": "MedicalCode", "code": "D000320", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.671.501.075" } } }, { "@type": "MedicalWebPage", "name": "Neurofibres autonomes postganglionnaires", "alternateName": "Autonomic Fibers, Postganglionic", "url": "https://questionsmedicales.fr/mesh/D001338", "about": { "@type": "MedicalCondition", "name": "Neurofibres autonomes postganglionnaires", "code": { "@type": "MedicalCode", "code": "D001338", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.671.501.100" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Neurofibres sympathiques postganglionnaires", "alternateName": "Sympathetic Fibers, Postganglionic", "url": "https://questionsmedicales.fr/mesh/D017779", "about": { "@type": "MedicalCondition", "name": "Neurofibres sympathiques postganglionnaires", "code": { "@type": "MedicalCode", "code": "D017779", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.671.501.100.800" } } } ] }, { "@type": "MedicalWebPage", "name": "Axones", "alternateName": "Axons", "url": "https://questionsmedicales.fr/mesh/D001369", "about": { "@type": "MedicalCondition", "name": "Axones", "code": { "@type": "MedicalCode", "code": "D001369", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.671.501.145" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Segment initial de l'axone", "alternateName": "Axon Initial Segment", "url": "https://questionsmedicales.fr/mesh/D000071040", "about": { "@type": "MedicalCondition", "name": "Segment initial de l'axone", "code": { "@type": "MedicalCode", "code": "D000071040", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.671.501.145.250" } } }, { "@type": "MedicalWebPage", "name": "Cônes de croissance", "alternateName": "Growth Cones", "url": "https://questionsmedicales.fr/mesh/D020439", "about": { "@type": "MedicalCondition", "name": "Cônes de croissance", "code": { "@type": "MedicalCode", "code": "D020439", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.671.501.145.375" } } }, { "@type": "MedicalWebPage", "name": "Fibres moussues de l'hippocampe", "alternateName": "Mossy Fibers, Hippocampal", "url": "https://questionsmedicales.fr/mesh/D019599", "about": { "@type": "MedicalCondition", "name": "Fibres moussues de l'hippocampe", "code": { "@type": "MedicalCode", "code": "D019599", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.671.501.145.438" } } }, { "@type": "MedicalWebPage", "name": "Terminaisons présynaptiques", "alternateName": "Presynaptic Terminals", "url": "https://questionsmedicales.fr/mesh/D017729", "about": { "@type": "MedicalCondition", "name": "Terminaisons présynaptiques", "code": { "@type": "MedicalCode", "code": "D017729", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.671.501.145.750" } } }, { "@type": "MedicalWebPage", "name": "Collatéraux de Schaffer", "alternateName": "Schaffer Collaterals", "url": "https://questionsmedicales.fr/mesh/D000094282", "about": { "@type": "MedicalCondition", "name": "Collatéraux de Schaffer", "code": { "@type": "MedicalCode", "code": "D000094282", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.671.501.145.875" } } } ] }, { "@type": "MedicalWebPage", "name": "Neurofibres cholinergiques", "alternateName": "Cholinergic Fibers", "url": "https://questionsmedicales.fr/mesh/D002799", "about": { "@type": "MedicalCondition", "name": "Neurofibres cholinergiques", "code": { "@type": "MedicalCode", "code": "D002799", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.671.501.234" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Neurofibres autonomes préganglionnaires", "alternateName": "Autonomic Fibers, Preganglionic", "url": "https://questionsmedicales.fr/mesh/D001339", "about": { "@type": "MedicalCondition", "name": "Neurofibres autonomes préganglionnaires", "code": { "@type": "MedicalCode", "code": "D001339", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.671.501.234.060" } } }, { "@type": "MedicalWebPage", "name": "Neurofibres parasympathiques postganglionnaires", "alternateName": "Parasympathetic Fibers, Postganglionic", "url": "https://questionsmedicales.fr/mesh/D017777", "about": { "@type": "MedicalCondition", "name": "Neurofibres parasympathiques postganglionnaires", "code": { "@type": "MedicalCode", "code": "D017777", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.671.501.234.700" } } } ] }, { "@type": "MedicalWebPage", "name": "Gaine de myéline", "alternateName": "Myelin Sheath", "url": "https://questionsmedicales.fr/mesh/D009186", "about": { "@type": "MedicalCondition", "name": "Gaine de myéline", "code": { "@type": "MedicalCode", "code": "D009186", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.671.501.512.560" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Gaine de Schwann", "alternateName": "Neurilemma", "url": "https://questionsmedicales.fr/mesh/D009441", "about": { "@type": "MedicalCondition", "name": "Gaine de Schwann", "code": { "@type": "MedicalCode", "code": "D009441", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.671.501.512.560.550" } } }, { "@type": "MedicalWebPage", "name": "Noeuds de Ranvier", "alternateName": "Ranvier's Nodes", "url": "https://questionsmedicales.fr/mesh/D011901", "about": { "@type": "MedicalCondition", "name": "Noeuds de Ranvier", "code": { "@type": "MedicalCode", "code": "D011901", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.671.501.512.560.700" } } } ] }, { "@type": "MedicalWebPage", "name": "Neurofibres non-myélinisées", "alternateName": "Nerve Fibers, Unmyelinated", "url": "https://questionsmedicales.fr/mesh/D036421", "about": { "@type": "MedicalCondition", "name": "Neurofibres non-myélinisées", "code": { "@type": "MedicalCode", "code": "D036421", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.671.501.756" } } } ], "about": { "@type": "MedicalCondition", "name": "Neurofibres", "alternateName": "Nerve Fibers", "code": { "@type": "MedicalCode", "code": "D009412", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Z V Surnina", "url": "https://questionsmedicales.fr/author/Z%20V%20Surnina", "affiliation": { "@type": "Organization", "name": "Krasnov Research Institute of Eye Diseases, Moscow, Russia." } }, { "@type": "Person", "name": "S E Avetisov", "url": "https://questionsmedicales.fr/author/S%20E%20Avetisov", "affiliation": { "@type": "Organization", "name": "Krasnov Research Institute of Eye Diseases, Moscow, Russia." } }, { "@type": "Person", "name": "Yao-Chuan Chang", "url": "https://questionsmedicales.fr/author/Yao-Chuan%20Chang", "affiliation": { "@type": "Organization", "name": "Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, 11030, USA." } }, { "@type": "Person", "name": "Stavros Zanos", "url": "https://questionsmedicales.fr/author/Stavros%20Zanos", "affiliation": { "@type": "Organization", "name": "Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, 11030, USA. Electronic address: szanos@northwell.edu." } }, { "@type": "Person", "name": "Elçin Tunçkol", "url": "https://questionsmedicales.fr/author/El%C3%A7in%20Tun%C3%A7kol", "affiliation": { "@type": "Organization", "name": "Bernstein Center for Computational Neuroscience Berlin, Humboldt-Universität zu Berlin, Philippstrasse 13, Haus 6, Berlin, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "New Horizons of Model Informed Drug Development in Rare Diseases Drug Development.", "datePublished": "2024-07-11", "url": "https://questionsmedicales.fr/article/38989644", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/cpt.3366" } }, { "@type": "ScholarlyArticle", "name": "Development and Modification of New or Recycled Materials and Technological Processes towards Sustainable Development.", "datePublished": "2024-06-21", "url": "https://questionsmedicales.fr/article/38998142", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ma17133060" } }, { "@type": "ScholarlyArticle", "name": "Development and validation of the newly developed Preschool Theory of Mind Assessment (ToMA-P).", "datePublished": "2024-04-08", "url": "https://questionsmedicales.fr/article/38650906", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpsyg.2024.1274204" } }, { "@type": "ScholarlyArticle", "name": "The Efficacy of \"Care for Child Development\" Intervention on the Improvement of the Development Skills of Orphanage Children.", "datePublished": "2023-10-26", "url": "https://questionsmedicales.fr/article/38074937", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.22037/ijcn.v17i2.38644" } }, { "@type": "ScholarlyArticle", "name": "Developability assessment at early-stage discovery to enable development of antibody-derived therapeutics.", "datePublished": "2022-11-11", "url": "https://questionsmedicales.fr/article/36683767", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1093/abt/tbac029" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Cellules", "item": "https://questionsmedicales.fr/mesh/D002477" }, { "@type": "ListItem", "position": 3, "name": "Neurones", "item": "https://questionsmedicales.fr/mesh/D009474" }, { "@type": "ListItem", "position": 4, "name": "Neurofibres", "item": "https://questionsmedicales.fr/mesh/D009412" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Neurofibres - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Neurofibres", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Neurofibres", "description": "Comment diagnostiquer une neuropathie ?\nQuels tests pour évaluer les neurofibres ?\nLes IRM sont-elles utiles pour les neurofibres ?\nQuels signes indiquent une atteinte des neurofibres ?\nComment évaluer la conduction nerveuse ?", "url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Language+Development+Disorders&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Neurofibres", "description": "Quels sont les symptômes d'une neuropathie ?\nComment se manifeste une neuropathie périphérique ?\nLes symptômes varient-ils selon le type de neurofibres ?\nPeut-on avoir des symptômes sans lésions visibles ?\nLes symptômes s'aggravent-ils avec le temps ?", "url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Language+Development+Disorders&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Neurofibres", "description": "Comment prévenir les neuropathies ?\nL'exercice régulier aide-t-il à prévenir les neuropathies ?\nLes habitudes alimentaires influencent-elles les neurofibres ?\nFumer augmente-t-il le risque de neuropathie ?\nLe stress a-t-il un impact sur les neurofibres ?", "url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Language+Development+Disorders&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Neurofibres", "description": "Quels traitements existent pour les neuropathies ?\nLes médicaments peuvent-ils soulager la douleur nerveuse ?\nLa physiothérapie aide-t-elle les patients ?\nQuand envisager une intervention chirurgicale ?\nLes traitements sont-ils efficaces pour tous ?", "url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Language+Development+Disorders&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Neurofibres", "description": "Quelles complications peuvent survenir avec une neuropathie ?\nLa neuropathie peut-elle entraîner des amputations ?\nLes troubles de la marche sont-ils une complication ?\nPeut-on développer une dépression à cause de la neuropathie ?\nLes complications sont-elles réversibles ?", "url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Language+Development+Disorders&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Neurofibres", "description": "Quels sont les principaux facteurs de risque de neuropathie ?\nL'âge influence-t-il le risque de neuropathie ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe diabète est-il un facteur de risque majeur ?\nLes carences nutritionnelles augmentent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Language+Development+Disorders&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une neuropathie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un examen neurologique, des tests électrophysiologiques et des analyses sanguines sont utilisés." } }, { "@type": "Question", "name": "Quels tests pour évaluer les neurofibres ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'électromyographie (EMG) et les potentiels évoqués sont couramment utilisés." } }, { "@type": "Question", "name": "Les IRM sont-elles utiles pour les neurofibres ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les IRM peuvent visualiser les lésions nerveuses et les anomalies des neurofibres." } }, { "@type": "Question", "name": "Quels signes indiquent une atteinte des neurofibres ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs, des engourdissements ou une faiblesse musculaire peuvent indiquer une atteinte." } }, { "@type": "Question", "name": "Comment évaluer la conduction nerveuse ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de conduction nerveuse mesurent la vitesse des signaux dans les neurofibres." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une neuropathie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur, picotements, faiblesse musculaire et perte de sensation." } }, { "@type": "Question", "name": "Comment se manifeste une neuropathie périphérique ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par des douleurs, des engourdissements et des réflexes diminués." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de neurofibres ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes dépendent du type de neurofibres affectées (sensitives, motrices)." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans lésions visibles ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes peuvent survenir sans lésions visibles sur les examens d'imagerie." } }, { "@type": "Question", "name": "Les symptômes s'aggravent-ils avec le temps ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, les symptômes peuvent s'aggraver progressivement sans traitement." } }, { "@type": "Question", "name": "Comment prévenir les neuropathies ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir un mode de vie sain, contrôler le diabète et éviter les toxines peuvent aider." } }, { "@type": "Question", "name": "L'exercice régulier aide-t-il à prévenir les neuropathies ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier améliore la circulation sanguine et la santé nerveuse." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles les neurofibres ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée riche en vitamines B peut soutenir la santé nerveuse." } }, { "@type": "Question", "name": "Fumer augmente-t-il le risque de neuropathie ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut endommager les vaisseaux sanguins et affecter les nerfs." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur les neurofibres ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut exacerber les symptômes nerveux et affecter la santé globale." } }, { "@type": "Question", "name": "Quels traitements existent pour les neuropathies ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent médicaments, thérapies physiques et interventions chirurgicales." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils soulager la douleur nerveuse ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des analgésiques et des anticonvulsivants sont souvent prescrits pour soulager la douleur." } }, { "@type": "Question", "name": "La physiothérapie aide-t-elle les patients ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la physiothérapie peut améliorer la force musculaire et la coordination." } }, { "@type": "Question", "name": "Quand envisager une intervention chirurgicale ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une chirurgie est envisagée si les symptômes sont graves et ne répondent pas aux traitements conservateurs." } }, { "@type": "Question", "name": "Les traitements sont-ils efficaces pour tous ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité des traitements varie selon la cause et la gravité de la neuropathie." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une neuropathie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des infections, des blessures et des problèmes d'équilibre." } }, { "@type": "Question", "name": "La neuropathie peut-elle entraîner des amputations ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des lésions nerveuses sévères peuvent augmenter le risque d'amputation, surtout chez les diabétiques." } }, { "@type": "Question", "name": "Les troubles de la marche sont-ils une complication ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la neuropathie peut affecter la coordination et entraîner des troubles de la marche." } }, { "@type": "Question", "name": "Peut-on développer une dépression à cause de la neuropathie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la douleur chronique et les limitations fonctionnelles peuvent contribuer à la dépression." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque de neuropathie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent le diabète, l'alcoolisme, les infections et certaines maladies auto-immunes." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de neuropathie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de neuropathie augmente avec l'âge en raison de la dégradation nerveuse." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de neuropathie peuvent augmenter le risque individuel." } }, { "@type": "Question", "name": "Le diabète est-il un facteur de risque majeur ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète est l'un des principaux facteurs de risque de neuropathie périphérique." } }, { "@type": "Question", "name": "Les carences nutritionnelles augmentent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des carences en vitamines B et en acide folique peuvent augmenter le risque de neuropathie." } } ] } ] }

Sources (10000 au total)

Development and validation of the newly developed Preschool Theory of Mind Assessment (ToMA-P).

Theory of mind (ToM) refers to the ability to understand and attribute mental states to oneself and others. A ToM measure is warranted for preschool children to assess their ToM development from a mul... The ToMA-P was developed based on comprehensive literature review and revised with expert panel feedback. Its psychometric properties were evaluated in 205 typically developing preschoolers with Rasch... The results indicated that all ToMA-P items, except for one, fit the hypothesized two-dimensional construct. The item difficulties in the cognitive and affective dimensions followed developmental sequ... This study provides empirical evidence that the ToMA-P measures cognitive and affective ToM following developmental sequences, and that it has potential as a clinical tool for assessing ToM in prescho...

The Efficacy of "Care for Child Development" Intervention on the Improvement of the Development Skills of Orphanage Children.

Development refers to the progressive enhancement of skills and functional capacity, i.e., qualitative changes in the child's functions. The process of development begins before birth and continues th... In this study, two orphanages in the capitals of East and West Azerbaijan provinces were selected using the convenience sampling technique, and thirty children were included. Then, they were randomly ... Comparing the two control and intervention groups using the T-test (difference in mean) indicates that except for the domain of cognitive skills (Bayley: P-value = 0.176), there was statistically a si... In the present study, it was concluded that it is required to apply interventions, including standard ones such as the CCD program in environments like orphanages, to enhance the developmental skills ...

How does the increase in eating difficulties according to the Development and Well-Being Assessment screening items relate to the population prevalence of eating disorders? An analysis of the 2017 Mental Health in Children and Young People survey.

We examine the test accuracy of the Development and Well-Being Assessment (DAWBA) eating disorder screening items to explore whether the increased eating difficulties detected in the English National ... Study 1 calculated sensitivity, specificity, and positive and negative predictive values from responses to the DAWBA screening items from 4057 11-19-year-olds and their parents, in the 2017 MHCYP surv... Parental report most accurately predicted an eating disorder (93.6%, 95% confidence interval: 92.7-94.5). Sensitivity increased when parent and child answers were combined, and with a higher threshold... We found tentative evidence of increased population prevalence of eating disorders, particularly among young men. Despite this, the DAWBA screening items are useful for ruling out eating disorders, pa... The prevalence of eating disorders did not markedly change from 2017 to 2021, but we found tentative evidence of an increase, particularly among young men. This is despite larger increases in problema...

Etiologic Factors of Temporomandibular Disorders: A Systematic Review of Literature Containing Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) and Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) from 2018 to 2022.

This study aims to conduct a systematic analysis of literature published between 1 January 2018 and 1 September 2022, exploring factors influencing the progression or development of temporomandibular ...

Does food use disorder exist? Item response theory analyses of a food use disorder adapted from the DSM-5 substance use disorder criteria in a treatment seeking clinical sample.

Increased consumption of food that are high in energy and sugar have been pointed as a major factor in the obesity epidemic. Impaired control of food intake and the concept of food addiction has been ... Cross-sectional observational study including 508 participants (56.1% male; mean age 42.2) from outpatient treatment clinics for obesity or addiction disorders at time of admission. FUD diagnostic cri... We demonstrated the one-factor dimensionality of the criteria set. The criterion "craving" presented the strongest factor loading and discrimination parameter and the second-lowest difficulty. We foun... This study reports, for the first time, the validity of a potential Food Use Disorder (derived from the 11 DSM-5 SUD criteria adapted to food) in a sample of treatment seeking adults. This has great i...